Ulcer risk factors: Interactions between Helicobacter pylori infection, nonsteroidal use, and age

The American Journal of Medicine

Volumn 94, Issue 4, 1993, Pages 413-418

  Schubert, Timothy T ^a   Bologna, Sante D ^a   Nensey, Yawer ^a   Schubert, Arlene B ^a   Mascha, Edward J ^a   MA, Chan K ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ADULT; AGING; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG USE; DUODENUM ULCER; ENDOSCOPY; ETHNIC GROUP; FEMALE; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; STOMACH BIOPSY; STOMACH ULCER;

ADULT; AGE FACTORS; ALCOHOL DRINKING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BIOPSY; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGE; PEPTIC ULCER; QUESTIONNAIRES; RACIAL STOCKS; RECURRENCE; REFERRAL AND CONSULTATION; RISK FACTORS; SEX FACTORS; SMOKING; STOMACH DISEASES;

EID: 0027406320     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(93)90153-G     Document Type: Article

References (62)

1. Gastric ulcer
2. Duodenal ulcer and drug therapy
3. Pathogenesis of peptic ulcer and implications for therapy
4. Sex differences in peptic ulcer disease
5. Cigarettes, alcohol, coffee and peptic ulcer
6. Relative impact of smoking and reduced pulmonary function on peptic ulcer risk
7. Outpatient endoscopic survey of smoking and peptic ulcer
8. Smoking, alcohol, analgesics and chronic duodenal ulcer
9. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer
10. Cigarettes, alcohol, coffee and peptic ulcer
11. Ulcers, nonsteroidal anti-inflammatory drugs, and related matters
12. The relationship between nonsteroidal anti-inflammatory drug use and peptic ulcer disease
13. Epidemiologic evidence on the association between peptic ulceration and anti-inflammatory drug use
14. Analgesic ingestion and chronic peptic ulcer
15. Peptic ulcer and non-steroidal anti-inflammatory agents
16. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration
17. The effect of chronic aspirin use on duodenal and gastric ulcers [abstract]
18. Smoking, non-steroidal anti-inflammatory drugs, and acetaminophen in gastric ulcer
19. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons
20. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen nov as Helicobacter pylori comb nov and Helicobacter mustelae comb nov respectively
21. The clinical significance of Campylobacter pylori
22. Gastric campylobacter-like organisms, gastritis, and peptic ulcer disease
23. The Campylobacter pylori story
24. Campylobacter gastritis and associated disorders
25. Helicobacter pylori: controversies and an approach to management
26. Campylobacter pylori and peptic ulcer disease
27. Campylobacter pylori ana its role in peptic ulcer disease
28. Usefulness of culture, histology, and urease testing in the detection of Campylobacter pylori
29. Prevalence of Campylobacter pylori in patients undergoing upper endoscopy
30. Campylobacter pylori, the organism and its clinical relevance
31. Peptic ulcer—an infectious disease?
32. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing; a randomized controlled trial
33. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori
34. Campylobacter pylori and recurrence of duodenal ulcers a 12 month follow-up study
35. Eradication of Helicobacter pylori cures duodenal ulcer [abstract]
36. A prospective study of Helicobacter pylori eradication in duodenal ulcer
37. A comparison of ranitidine and tripotassium dicitrato-bismuth (T.D.B.) in relapse rates of duodenal ulcer. The role of Campylobacter pylori (C.P.) [abstract]
38. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized controlled study
39. Environmental factors in aetiology of chronic gastric culer: a case control study of exposure variables before the first symptoms
40. Non-steroidal anti-inflammatory drugs and peptic ulceration
41. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983
42. Nonsteroidal anti-inflammatory drugs and peptic ulcer perforation
43. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons
44. Nonsteroidal anti-inflammatory drugs and hospitalization for perforated peptic ulcer
45. Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly
46. Certain nonsteroidal anti-inflammatory drugs and hospitalization for upper gastrointestinal bleeding
47. Utilization of nonsteroidal anti-inflammatory drugs
48. The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations
49. Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo or indomethacin
50. The effect of Helicobacter pylori (H. PYLORI) “toxin” on human gastric mucosa and its interaction with indomethacin [abstract]
51. Campylobacter pylori, NSAIDs, and smoking: risk factors for peptic ulcer disease
52. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury; the role of Helicobacter pylori
53. The incidence of duodenal and gastric ulcers in a large health maintenance organization
54. Prevalence of peptic ulcer in India: an endoscopic and epidemiological study in urban Kashmir
55. The influence of sex, race and dialect on peptic ulcer and non-ulcer dyspepsia in Singapore
56. Natural history and epidemiologic studies of peptic ulcer disease in Japan
57. Endoscopy in peptic diseases and bleeding: a community survey of 1635 patients
58. Incidence of peptic ulcer disease in Gothenburg
59. Racial differences in peptic ulcer disease: fact or myth?
60. Smoking and duodenal ulcer
61. Famotidine therapy for active duodenal ulcers, a multivariate analysis of factors affecting early healing